Graf Akcie ESPR (Esperion Therapeutics Inc.). Diskuze k akciím ESPR. Aktuální informace ESPR.

Základní informace o společnosti Esperion Therapeutics Inc. (Akcie ESPR)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	262.19M
Hodnota podniku (EV)	N/A
Tržby	62.108M
EBITDA	N/A
Zisk	-324.52
Růst v tržbách Q/Q	-80.84 %
Růst v tržbách Y/Y	-71.25 %
P/E (Cena vůči ziskům)	0.00
Forward P/E	N/A
EV/Sales	6.61
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	4.22
P/FCF	N/A
Price/Book	-2.73
Účetní hodnota na akcii	-3.42
Hotovost na akcii	10.85
FCF vůči ceně	-111.47 %
Počet zaměstnanců	479
Tržba na zaměstnance	129.662k
Profit margin	-63.09 %
Operating margin	-469.31 %
Gross margin	98.95 %
EBIT margin	-469.16 %
EBITDA margin	-42.39 %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	-138.66 %
EPS - Očekávaný růst příští rok	-9.12 %
Return on assets	-111.59 %
Return on equity	196.42 %
ROIC	-42.59 %
ROCE	-147.30 %
Dluhy/Equity	-4.67
Čistý dluh/EBITDA	2.42
Current ratio	3.33
Quick Ratio	3.04
Volatilita	7.19
Beta	0.38
RSI	28.44
Cílová cena analytiků	76
Známka akcie (dle analytiků)	1.91
Insider ownership	N/A %
Institutional ownership	N/A %
Počet akcií	28.277M
Procento shortovaných akcií	49.77 %
Short ratio	14.35 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	2013
Země	United States

Finanční výsledky akcie ESPR

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	$227.547	$148.364	-	-	-	-
Cost Of Goods Sold	$2.392	-	-	-	-	-
Gross Profit	$225.155	$148.364	-	-	-	-
Research And Development Expenses	$146.936	$175.611	$171.488	$147.603	$57.868	$29.802
SG&A Expenses	$199.615	$65.854	$33.097	$21.379	$18.282	$20.238
Other Operating Income Or Expenses	-	-	-	-	-	-
Operating Expenses	$348.943	$241.465	$204.585	$168.982	$76.15	$50.04
Operating Income	$-121.396	$-93.101	$-204.585	$-168.982	$-76.15	$-50.04
Total Non-Operating Income/Expense	$-22.155	$-4.064	$2.775	$1.994	$1.172	$0.256
Pre-Tax Income	$-143.551	$-97.165	$-201.81	$-166.988	$-74.978	$-49.784
Income Taxes	-	-	-	-	-	-
Income After Taxes	$-143.551	$-97.165	$-201.81	$-166.988	$-74.978	$-49.784
Other Income	-	-	-	-	-	-
Income From Continuous Operations	$-143.551	$-97.165	$-201.81	$-166.988	$-74.978	$-49.784
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	$-143.551	$-97.165	$-201.81	$-166.988	$-74.978	$-49.784
EBITDA	$-119.205	$-92.982	$-204.537	$-168.39	$-74.884	$-49.096
EBIT	$-121.396	$-93.101	$-204.585	$-168.982	$-76.15	$-50.04
Basic Shares Outstanding	27	27	27	24	23	22
Shares Outstanding	27	27	27	24	23	22
Basic EPS	$-5.23	$-3.59	$-7.54	$-6.98	$-3.33	$-2.26
EPS - Earnings Per Share	$-5.23	$-3.59	$-7.54	$-6.98	$-3.33	$-2.26

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$304.962	$201.709	$136.023	$200.199	$211.583	$212.261
Receivables	-	-	-	-	-	-
Inventory	$16.136	-	-	-	-	-
Pre-Paid Expenses	$0.844	$6.081	$5.275	$2.072	$0.56	$0.888
Other Current Assets	$23.954	$3.924	$1.334	$1.653	$1.434	$1.245
Total Current Assets	$345.896	$211.714	$142.632	$203.924	$213.577	$214.394
Property, Plant, And Equipment	$1.276	$1.145	$0.52	$0.435	$0.674	$0.807
Long-Term Investments	-	-	$0.243	$73.42	$30.906	$80.315
Goodwill And Intangible Assets	$0.056	$0.056	$0.056	$0.056	$0.056	$0.056
Other Long-Term Assets	-	-	-	-	-	-
Total Long-Term Assets	$7.362	$2.733	$0.819	$73.911	$31.636	$81.178
Total Assets	$353.258	$214.447	$143.451	$277.835	$245.213	$295.572
Total Current Liabilities	$94.069	$66.08	$64.333	$33.144	$15.589	$5.625
Long Term Debt	$179.367	-	-	-	$1.022	$2.688
Other Non-Current Liabilities	$172.502	$127.308	-	-	-	-
Total Long Term Liabilities	$355.323	$128.417	-	-	$1.022	$2.688
Total Liabilities	$449.392	$194.497	$64.333	$33.144	$16.611	$8.313
Common Stock Net	$0.026	$0.027	$0.027	$0.026	$0.023	$0.023
Retained Earnings (Accumulated Deficit)	$-838.817	$-695.266	$-598.101	$-396.291	$-229.2	$-154.222
Comprehensive Income	-	$0.023	$-0.319	$-0.845	$-0.172	$-0.482
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$-96.134	$19.95	$79.118	$244.691	$228.602	$287.259
Total Liabilities And Share Holders Equity	$353.258	$214.447	$143.451	$277.835	$245.213	$295.572

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$-143.551	$-97.165	$-201.81	$-166.988	$-74.978	$-49.784
Total Depreciation And Amortization - Cash Flow	$2.191	$0.119	$0.048	$0.592	$1.266	$0.944
Other Non-Cash Items	$60.445	$34.004	$23.968	$18.605	$15.957	$12.773
Total Non-Cash Items	$62.636	$34.123	$24.016	$19.197	$17.223	$13.717
Change In Accounts Receivable	-	-	-	-	-	-
Change In Inventories	$-16.136	-	-	-	-	-
Change In Accounts Payable	$23.106	$-16.055	$24.446	$15.758	$3.888	$-1.333
Change In Assets/Liabilities	$-11.232	$8.756	$4.71	$0.731	$6.137	$-0.756
Total Change In Assets/Liabilities	$-4.262	$-7.299	$29.156	$16.489	$10.025	$-2.089
Cash Flow From Operating Activities	$-85.177	$-70.341	$-148.638	$-131.302	$-47.73	$-38.156
Net Change In Property, Plant, And Equipment	$-0.869	$-0.953	$-0.151	$-0.019	$-0.094	$-0.301
Net Change In Intangible Assets	-	-	-	-	-	-
Net Acquisitions/Divestitures	-	-	-	-	-	-
Net Change In Short-term Investments	-	-	-	-	-	-
Net Change In Long-Term Investments	$34.725	$65.184	$140.6	$-35.834	$10.212	$-159.767
Net Change In Investments - Total	$34.725	$65.184	$140.6	$-35.834	$10.212	$-159.767
Investing Activities - Other	$-12.5	-	-	-	-	-
Cash Flow From Investing Activities	$21.356	$64.231	$140.449	$-35.853	$10.118	$-160.068
Net Long-Term Debt	$280	-	$-1.049	$-1.709	$-1.604	$-0.638
Net Current Debt	$-46.004	-	-	-	-	-
Debt Issuance/Retirement Net - Total	$233.996	-	$-1.049	$-1.709	$-1.604	$-0.638
Net Common Equity Issued/Repurchased	$-48.366	$11.771	$11.743	$165.167	$0.045	$191.16
Net Total Equity Issued/Repurchased	$-48.366	$11.771	$11.743	$165.167	$0.045	$191.16
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	$16.095	$124.424	-	-	-	-
Cash Flow From Financial Activities	$201.725	$136.195	$10.694	$163.458	$-1.559	$190.522
Net Cash Flow	$137.904	$130.085	$2.505	$-3.697	$-39.171	$-7.702
Stock-Based Compensation	$28.385	$25.884	$23.968	$18.605	$15.957	$12.726
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	3.677	3.2039	2.2171	6.1527	13.7005	38.1145
Long-term Debt / Capital	2.155	-	-	-	0.0045	0.0093
Debt/Equity Ratio	-1.8658	-	-	0.0043	0.0119	0.0149
Gross Margin	98.9488	100	-	-	-	-
Operating Margin	-53.3499	-62.7518	-	-	-	-
EBIT Margin	-53.3499	-62.7518	-	-	-	-
EBITDA Margin	-52.387	-62.6715	-	-	-	-
Pre-Tax Profit Margin	-63.0863	-65.491	-	-	-	-
Net Profit Margin	-63.0863	-65.491	-	-	-	-
Asset Turnover	0.6441	0.6918	-	-	-	-
Inventory Turnover Ratio	0.1482	-	-	-	-	-
Receiveable Turnover	-	-	-	-	-	-
Days Sales In Receivables	-	-	-	-	-	-
ROE - Return On Equity	149.3239	-487.0425	-255.0749	-68.2444	-32.7985	-17.3307
Return On Tangible Equity	149.2369	-488.4133	-255.2554	-68.2601	-32.8065	-17.3341
ROA - Return On Assets	-40.6363	-45.3096	-140.6822	-60.1033	-30.5767	-16.8433
ROI - Return On Investment	-172.4688	-487.0426	-255.0747	-68.2444	-32.6525	-17.17
Book Value Per Share	-3.7094	0.7255	2.9494	9.3021	10.1353	12.7563
Operating Cash Flow Per Share	-0.5037	2.9591	-0.0695	-3.369	-0.3844	0.2228
Free Cash Flow Per Share	-0.5002	2.9297	-0.0744	-3.3656	-0.3749	0.2617

Warning: Undefined array key "user" in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php on line 716

Fatal error: Uncaught mysqli_sql_exception: You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'AND valid >= CURDATE()' at line 2 in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php:11 Stack trace: #0 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php(11): mysqli_query(Object(mysqli), 'SELECT * FROM p...') #1 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php(716): Database::Execute(Object(mysqli), 'SELECT * FROM p...') #2 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(20): require_once('/data/web/virtu...') #3 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): {closure}() #4 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): Closure->__invoke() #5 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(21): Route::set('graf-akcie/ESPR', Object(Closure)) #6 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/index.php(23): require_once('/data/web/virtu...') #7 {main} thrown in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php on line 11

JenAkcie

Graf Akcie ESPR (Esperion Therapeutics Inc.). Diskuze k akciím ESPR. Aktuální informace ESPR.

Základní informace o společnosti Esperion Therapeutics Inc. (Akcie ESPR)

Finanční výsledky akcie ESPR